https://www.theguardian.com/world/2021/jun/14/how-taiwan-struggle-for-covid-vaccines-is-inflaming-tensions-with-china
以上是偏DPP说中国从中作梗的说法 就不译了 反正民众大外宣也听多了
以下开始是不利DPP的
If Taiwan accepted Chinese vaccines it would be the political “
kiss of death for the DPP [Taiwan’s ruling party]”, Thompson
said. “It’s quite likely China would take some sort of gratuitous
swipe … see it as a capitulation or recognition of Beijing’s
superiority.”
负责管理与中国和台湾双边关系的前美国国防部官员德鲁·
汤普森表示，如果台湾接受了中国疫苗，这将是“民进党
(台湾执政党) 的政治“死亡之吻”。“中国很可能会采取某
种无理由的攻击……将其视为对北京优势的投降或承认。”
China said Fosun – the Shanghai-based manufacturer with
exclusive regional production rights for Pfizer/BioNTech – had
offered to supply Taiwan, but Taiwan had refused.
中国表示，拥有辉瑞/BioNTech 独家区域生产权的上海制造
商复星曾提出向台湾供货，但台湾拒绝了。
Thompson said there were scientific and transparency concerns
about China’s vaccines, which made it unsurprising and
potentially sensible for Taiwan to reject an offer of
Chinese-developed vaccines. But if the Fosun offer is legitimate,
refusing it is “entirely political”.
汤普森说，中国的疫苗存在科学和透明度面的顾虑，因此台
湾拒绝提供中国开发的疫苗并不意外而且合理。但如果复星
的提议是合法的，拒绝提议则“完全是政治性的”。
“Pfizer and BioNTech have a huge incentive to ensure that the
Fosun product is equivalent, so I would think there is no concern,”
he said. “There’s no reason not to take it.”
“辉瑞和 BioNTech 有重大诱因来确保复星产品是等效的
，所以我认为没什么顾虑，”他说。“没有理由不接受。”
Polling has shown Taiwanese people are largely opposed to
receiving a Chinese-made vaccine, but not necessarily to a foreign
vaccine produced in China, like the Fosun/BioNtech one.
民意调查显示，台湾人在很大程度上反对中国制造的疫苗，
但不一定反对在中国生产的外国疫苗，例如复星/BioNtech。
The push for domestic vaccines
推动国产疫苗
Approval ratings for Taiwan’s president, Tsai Ing-wen, have
plummeted from more than 70% to about 40% in the 12 months
since her re-election, and her government is taking political heat for
the outbreak and the vaccine shortage.
台湾总统蔡英文的支持度在她连任后的 12 个月内从超过
70% 暴跌至约 40%，她的政府正在为疫情爆发和疫苗短缺承
受政治压力。
Before the current outbreak in Taiwan, so few members of priority
groups were booking shots that authorities briefly opened
vaccination up to the general population. But now community
appetite is bigger than available supplies.
在台湾目前的疫情爆发之前，几乎没有优先群体的成员预约
疫苗注射，以至于当局短暂向一般人群开放疫苗接种。但现
在社群消化量大于供应量。
The health minister, Chen Shih-chung, said Taiwan hoped to have
60% of the population receive at least one shot by October – a
target that requires about 12m doses and depends on no more
delayed orders and on the production of domestic vaccines.
卫福部长陈时中表示，台湾希望在 10 月之前让 60% 的人口
至少接受一剂注射──此目标需要约 1200 万剂，且取决于
不再延迟的外国订单及国内疫苗的生产。
On Thursday, Chen said Taiwan had held talks with AstraZeneca to
produce its vaccine but that the talks had fallen through. He
previously said Taiwan was in talks with US companies about
making their vaccines, though he did not name them.
周四，陈表示台湾与阿斯利康曾就生产疫苗一事进行对谈，
但对谈已告吹。他此前曾表示，台湾正在与美国公司就生产
疫苗进行谈判，但他没有透露公司名称。
Last week, a member of Taiwan’s vaccine review board who had
recently resigned accused Tsai of putting undue pressure on the
panel to approve domestic vaccines still in trial stage, when she
publicly announced she expected doses to be available by July.
上周，一位最近辞职的台湾疫苗审查委员会成员指控蔡对委
员会施加不当压力，要求核准仍处于试验阶段的国产疫苗
──当时她公开宣布，她预计将在 7 月之前供应疫苗。
Under pressure, the government has said private organisations can
import vaccines, though this is yet to happen and the offer is
complicated by the fact that most vaccine manufacturers prefer to
deal directly with governments.
迫于压力，政府已表示私人机构可以进口疫苗，尽管这件事
仍未发生，而且由于大多数疫苗制造商较愿意直接与政府打
交道，此一提议变得更为复杂。
The opposition Kuomintang party and several politicians at the
local county level have sought to capitalise on the vaccine
difficulties, leading to political slanging matches. But Lev
Nachman, a visiting scholar at the National Taiwan University, said
it still seemed “in the DPP’s electoral interest not to get any
China vaccines”.
反对党国民党和地方县市级的几位政治人物试图利用这次的
疫苗困境，从而导致双方政治谩骂的对战。但国立台湾大学
客座学者列夫纳赫曼表示，但现状看来似乎仍是“不接受任
何中国疫苗符合民进党的选举利益”。
Vaccine doses are being steadily administered to priority groups,
and a domestic vaccine candidate announced it would seek
emergency approval on Thursday. Nachman said these
developments might keep the DPP’s head above the political
water, but if not, the question of accepting Chinese vaccines could
become more realistic.
疫苗剂量正在稳定投药给优先群体，国内疫苗候选厂商宣布
将在周四寻求紧急核准。纳赫曼表示，这些事态发展可能会
使民进党免于陷身政治风暴，但如果不能，接受中国疫苗可
能会是更实际的作法。
“It would be foolish to say no, but it would be a measure of last
resort,” Nachman said.
“拒绝是愚蠢的，但这会是最后手段，”纳赫曼说。